Actively Recruiting
3D Assessment of RV Function in Patients Undergoing LVAD Implantation
Led by University of Alberta · Updated on 2025-05-25
200
Participants Needed
1
Research Sites
252 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This goal of this study is to analyze images of the right ventricle taken via 3D transesophageal echocardiography (TEE) during left ventricular assist device (LVAD) implantation.
CONDITIONS
Official Title
3D Assessment of RV Function in Patients Undergoing LVAD Implantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients receiving one of the following left-sided LVADs: HeartMate III, HeartWare HVAD, or Levitronix CentriMag
You will not qualify if you...
- Missing hemodynamic data needed to calculate PAPi or comprehensive echocardiographic images
- Additional procedures affecting cardiac geometry or hemodynamics performed at the time of LVAD implantation (e.g., tricuspid, mitral, or aortic valve repair/replacement)
- Inability to close the sternum at the end of the procedure
- Concurrent right ventricular mechanical support introduced with LVAD implantation
- Poor image quality preventing 3D protocol imaging
- Known contraindication to transesophageal echocardiography (TEE)
- Inability to advance the TEE probe into the mid-esophagus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mazankowski Alberta Heart Institute
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
Research Team
S
Surita Sidhu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here